Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Pegylated formulations of rHuTNF-alpha with improved properties prepared in China

July 30, 2001

FLT3 tyrosine kinase inhibitor exerts specific cytotoxicity against certain mutated AML blasts

July 30, 2001

Ilex enters into worldwide license agreement for MUC1 technology

July 30, 2001

Positive opinion from EMEA moves Foscan closer to approval

July 30, 2001

Abbott patents new series of peptide angiogenesis inhibitors

July 27, 2001

CancerVax to seek marketing approval of Canvaxin melanoma vaccine in Canada

July 27, 2001

Thalomid to be submitted for new indication this year

July 27, 2001

Elan licenses European rights to DepoCyte from SkyePharma

July 27, 2001

Antitumor bryostatin analogues synthesized at Leland Stanford

July 26, 2001

Preparation, telomerase-inhibitory and antitumor activity of new series from Aventis

July 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...